<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164854">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01963897</url>
  </required_header>
  <id_info>
    <org_study_id>2013/513</org_study_id>
    <nct_id>NCT01963897</nct_id>
  </id_info>
  <brief_title>Duchenne Muscular Dystrophy in Norway. Genotype/Phenotype in Patients Younger Than 18 Years, With a Main Focus on Growth, Puberty, Bone Health and Quality of Life.</brief_title>
  <official_title>Duchenne Muscular Dystrophy in Norway. Genotype/Phenotype in Patients Younger Than 18 Years, With a Main Focus on Growth, Puberty, Bone Health and Quality of Life.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Research Council of Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will give a consent based epidemiological overview of Norwegian patients with
      Duchenne muscular dystrophy younger than 18 years of age. Genotype of the population will be
      described. Longitudinal development of growth, bone health, and , when applicable, puberty
      over a two year period will be studied. Questionnaires regarding quality of life will also
      be an important part of the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Genotype</measure>
    <time_frame>1 day (At first visit)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Specific description of mutation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Duchenne Muscular Dystrophy</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with Duchenne muscular dystrophy under 18 years in Norway
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Duchenne muscular dystrophy

          -  Age under 18 years

          -  Residing in Norway

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnhild Rasmussen, Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellen J Annexstad, Cand.med.</last_name>
    <phone>02770</phone>
    <email>ellann@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magnhild Rasmussen, Dr.med.</last_name>
    <phone>02770</phone>
    <email>marasmus@ous-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen J Annexstad, Cand.med.</last_name>
      <phone>02770</phone>
      <email>ellann@ous-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Magnhild Rasmussen, Dr.med.</last_name>
      <phone>02770</phone>
      <email>marasmus@ous-hf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Ellen J Annexstad, Cand.med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magnhild Rasmussen, Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 21, 2013</lastchanged_date>
  <firstreceived_date>October 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Magnhild Rasmussen</investigator_full_name>
    <investigator_title>Dr.med.</investigator_title>
  </responsible_party>
  <keyword>Genotype/phenotype correlations</keyword>
  <keyword>Growth</keyword>
  <keyword>Bone health</keyword>
  <keyword>Puberty</keyword>
  <keyword>Quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
